The proteasome is a multicatalytic cellular complex present in human sperm that plays a significant role during several steps of mammalian fertilization. Here, we present evidence that the proteasome is involved in human sperm capacitation. Aliquots of highly motile sperm were incubated with proteasome inhibitors MG132 or epoxomicin. The percentage of capacitated sperm, the chymotrypsin-like activity of the proteasome, cAMP content, and the pattern of protein phosphorylation were assayed by using the chlortetracycline hydrochloride assay, a fluorogenic substrate, the cAMP enzyme immunoassay kit, and Western blot analysis, respectively. Our results indicate that treatment of sperm with proteasome inhibitors blocks the capacitation process, does not alter cAMP concentration, and changes the pattern of protein phosphorylation. To elucidate how proteasome activity is regulated during capacitation, sperm were incubated with: 1) tyrosine kinase (TK) inhibitors (genistein or herbimycin A); 2) protein kinase (PK) A inhibitors or activators (H89 and Rp-cAMPS, and 8-Br-cAMP, respectively); or 3) PKC inhibitors (tamoxifen or staurosporin) at different capacitation times. The chymotrypsin-like activity and degree of phosphorylation of the proteasome were then assayed. The results indicate that sperm treatment with TK and PKA inhibitors significantly decreases the chymotrypsin-like activity of the proteasome during capacitation. Immunoprecipitation and Western blot results suggest that the proteasome is phosphorylated during capacitation in a TK-and PKA-dependent pathway.
INTRODUCTION
Sperm capacitation involves a series of complex biochemical and physiological events that occur while the cells are traveling through the female genital tract [1] . Some of the changes that take place during this process include an increase in sperm plasma membrane fluidity due to cholesterol loss [2] , an increase in ionic influx by membrane hyperpolarization [3] , changes in cAMP concentration [4] , and an increase in the degree of protein phosphorylation [5] [6] [7] [8] [9] . These changes, among others, enable the sperm to change its movement pattern to ''hyperactivated,'' and to be able to undergo the acrosome reaction. These events are crucial for the fertilizing spermatozoon to penetrate the zona pellucida and fuse with the oocyte plasma membrane [1] .
Although the intracellular signaling pathways that lead to increased protein phosphorylation during sperm capacitation are not completely clear, different protein kinases (PKs) have been described in mammalian sperm, including tyrosine kinases (TK) [10] , PKA (PRKA) [11] , PKC (PRKC) [10, 12] , and glycogen synthase kinase (GSK) 3b [13] . These enzymes regulate the phosphorylation of several proteins at tyrosine and serine/threonine residues, thus regulating sperm function [8, 9, 13, 14] . In particular, it has been described that, during human sperm capacitation, there is an increase in the degree of tyrosine phosphorylation in proteins of 80 and 105 kDa (see [15] and references therein). The major proteins phosphorylated at tyrosine residues correspond to fibrous sheath proteins [16] . On the other hand, little is known about the phosphorylation of proteins at serine and threonine residues in mammalian sperm.
One protein complex susceptible to modification by regulated phosphorylation is the proteasome. The proteasome is a multienzymatic complex involved in nonlysosomal proteolysis of cytosolic and nuclear proteins that are abnormal, aged, or short lived [17] after they have been covalently labeled with ubiquitin molecules [18] . The proteolytic core of the proteasome is called the 20S proteasome, and is approximately 600 kDa. When this complex is associated with ATPase regulator and activator proteins, it constitutes the 26S proteasome of approximately 2000 kDa. The 20S core particle is made up of two copies each of seven different a and seven different b subunits arranged into four stacked rings. The two outer a rings are catalytically inactive, whereas three of the seven inner b subunits are catalytically active [19] with trypsinlike, chymotrypsin-like, and peptidylglutamyl peptide hydrolyzing (PGPH) activities [20, 21] . The 20S proteasome can fully degrade unfolded proteins in the absence of ATP and ubiquitin [22] ; however, the 26S proteasome degrades proteins in an ATP-dependent manner, and, in most cases, requires the presence of a ubiquitin chain on the substrate protein [23] .
Although little is known about proteasome regulation, numerous studies carried out in different cell types indicate that several subunits of the proteasome are phosphorylated at serine and tyrosine residues [24] [25] [26] . It is not clear, however, if differential phosphorylation of its subunits modulates proteasome activity, thereby regulating protein degradation. Some studies have shown that this phosphorylation is essential for the assembly of the regulator complex, 19S, with the 20S complex [27, 28] . In addition, there are reports indicating that phosphorylation of many proteins is a signal that triggers degradation by the proteasome pathway (see review in [18] ). In contrast, there are a few proteins (e.g., MOS, Fos and Jun) in which phosphorylation inhibits proteolysis, implying that nonphosphorylated forms are metabolically labile in the cell [29] [30] [31] .
The existence and function of the proteasome have been well characterized in spermatozoa of several species of marine invertebrates. In these species, the proteasome is tightly involved in multiple steps of fertilization, from the acrosome reaction induced by the egg jelly, to penetration of the viteline coat, and fusion with the plasma membrane of the female gamete [32, 33] . Recently, studies by Wojcik et al. [34] and Pizarro et al. [20] demonstrated the presence of the proteasome in mammalian sperm, including human sperm, and showed that this multienzymatic complex takes part in many events of mammalian fertilization. The sperm proteasome plays an active role during the zona pellucida-and progesterone-induced acrosome reaction and the calcium influx that precedes it [35] . It is still unknown, however, whether the sperm proteasome is involved during mammalian capacitation, including the changes in the protein phosphorylation pattern that takes place during this process. In addition, there are no studies related to the regulation of the sperm proteasome by PKs in spermatozoa.
The aim of the present work was to characterize the role of the proteasome during human sperm capacitation. In addition, we studied the relationship between proteasome activity and protein phosphorylation during this process, and whether the chymotrypsin-like activity of the sperm proteasome is regulated by PKs.
MATERIALS AND METHODS

Reagents and Antibodies
The following reagents were purchased from Sigma Chemical Co. 
0 ,5 0 -cyclic monophosphorothioate (Rp-cAMPS); staurosporine (St); herbimycin A; and 8-bromoadenosine-3 0 ,5 0 -cyclic monophosphate, sodium salt (8-Br-cAMP). The chemiluminescence detection and cAMP Direct Biotrak enzyme immunoassay (EIA) system kit no. RPN225 was purchased from Amersham Pharmacia Biotech (Piscataway, NJ). Immobilon P transfer membrane was obtained from Millipore Corporation (Bedford, MA). The RC DC Protein Assay was obtained from BioRad Laboratories, Inc. (Hercules, CA). Pisum sativum agglutinin (PSA)-FITC was purchased from Vector Laboratories, Inc. (Burlingame, CA).
The following antibodies were used: clone 4G10 anti-phosphotyrosine antibody (Upstate Biotechnology, Lake Placid, NY); mouse anti-phosphothreonine (42H4) no. 9386 (Cell Signaling, Danvers, MA); poly-Z-PS1 rabbit anti-phosphoserine (Zymed Laboratories Inc.); goat anti-rabbit biotinylated antibody, goat anti-mouse biotinylated antibody, and goat anti-mouse biotinylated immunoglobulin M antibody (Chemicon International, Temecula, CA). The anti-a-4 proteasome antibody and the agarose-immobilized anti-a-4 proteasome subunit were obtained from Affinity Research Products (Biomol Research Laboratories).
The deionized water used in these experiments was purified to .18 MX-cm with an EASY-pure UV/UF ion exchange system (Barnstead/Thermolyne, Dubuque, IA). Vectashield was purchased from Vector laboratories.
Semen Samples
Semen samples were obtained with the approval of the Ethics Committee of the University of Antofagasta after 2-3 days of sexual abstinence. All donors signed a form consenting to the use of their sperm cells for research purposes. All samples used were normal according to World Health Organization criteria [36] . Motile sperm were separated using a double Percoll gradient, as described previously [35] . Briefly, aliquots of semen were layered over the upper step of the Percoll gradient and centrifuged at 300 3 g for 20 min. The pellet was then resuspended in 10 ml of modified Tyrode medium consisting of 117.5 mM NaCl, 0.3 mM NaH 2 PO 4 , 8.6 mM KCl, 25 mM NaHCO 3 , 2.5 mM CaCl 2 , 0.5 mM MgCl 2 , 2 mM glucose, 0.25 mM sodium pyruvate, 19 mM sodium lactate, 70 lg/ml penicillin and streptomycin, phenol red, and 0.3 % BSA, and centrifuged again at 300 3 g for 10 min. Finally, the sperm pellet was resuspended in the same medium supplemented with 2.6% BSA. The sperm concentration was adjusted to 10 3 10 6 cells/ml, and the suspension was incubated at 378C, with 5% CO 2 in air for 0.5 (T0), 5 (T5), or 18 (T18) h.
Evaluation of Sperm Capacitation
To elucidate the role of the sperm proteasome during capacitation, we evaluated this process directly by using the CTC fluorescence assay, and indirectly by testing the ability of the sperm to undergo the acrosome reaction when stimulated with progesterone. It is well known that only capacitated sperm will undergo the acrosome reaction when challenged with a physiological stimulus [1] .
CTC Assay
The capacitation state of the spermatozoa was assessed using the CTC fluorescence assay method, as described previously [37, 38] . Briefly, CTC solution was prepared on the day of use and contained 750 lM CTC in a buffer of 130 mM NaCl, 5 mM cysteine, and 20 mM Tris-HCl, pH adjusted to 7.8. This solution was kept wrapped in foil at 48C until just before use. A 5-ll aliquot of a sperm suspension treated with 10 lg/ml Hoechst was placed on a slide at 378C; 5 ll of CTC stock solution was then rapidly added, followed within 30 sec by 0.5 ll of 2% glutaraldehyde in 1 M Tris buffer (pH 7.8). One drop of DABCO mounting medium was carefully mixed in to retard fading of the fluorescence, and a cover slip was placed on top. Cells were assessed for their living/dead state using ultraviolet light, as described previously [39] . In each sample, 200 live cells were assessed for CTC staining patterns, and, in all cases, the proportion of dead cells was very low. There were three main patterns of CTC fluorescence that could be identified: F, with uniform fluorescence over the entire head, characteristic of uncapacitated, acrosomeintact cells; B, with a fluorescence-free band in the postacrosomal region, characteristic of capacitated, acrosome-intact cells; and AR, with dull or absent fluorescence over the sperm head, characteristic of capacitated, acrosomereacted cells [37, 38] . At all three stages, bright fluorescence on the midpiece could be seen.
Progesterone-Induced Acrosome Reactions
Aliquots of highly motile spermatozoa were incubated for 18 h with 10 lM MG132 or its solvent (0.1% DMSO). At the end of the incubation period, the sperm were washed and resuspended twice in the same medium and then incubated for another 15 min with 7 lM progesterone or its solvent (0.1% DMSO). The acrosomal state and sperm viability were evaluated using FITClabeled PSA and the Hoechst 33258 dye, respectively, as described previously [39] . In this assay, the inhibitor was present only during capacitation; during the acrosome reaction stimulus, the sperm were incubated in inhibitor-free media.
Measurement of Total cAMP
Sperm aliquots (10 3 10 6 /ml) were incubated for 18 h in the presence or absence of 10 lM epoxomicin at 378C, 5% CO 2 . At the end of the incubation period, total cAMP production was quantified using the cAMP Direct Biotrak EIA system kit according to the manufacturer's instructions. Results are expressed as fmol/10 3 10 6 sperm/ml.
Preparation of Sperm Extracts
To measure the enzymatic activity of the proteasome, different sperm aliquots were washed in PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 4.3 mM Na 2 PO 4 , pH 7.4). The pellet was then resuspended in homogenization buffer (50 mM Hepes, 10% glycerol, 200 lM TLCK, pH 7.4) at a concentration of 200 3 10 6 cells/ml, and the sperm suspension was sonicated (Virsonic, Gardiner, NY) with seven 60-W bursts of 30 sec each, and centrifuged for 30 sec at 5000 3 g in a Beckman microfuge to remove nuclear and flagellar material [40] . The supernatant was used as the enzyme stock preparation. All of these procedures were performed at 48C.
For Western blot analysis and immunoprecipitation, protein extracts were prepared in radioimmunoprecipitation (RIPA) lysis buffer (150 mM NaCl, 50 mM Tris, 1% SDS, 2 mM Na 3 VO 4 , 50 mM NaF, 2 mM EDTA, 1% sodium desoxycholate, 1% NP-40, 1 mM PMSF, 10 lg/ml leupeptin, 10 lg/ml aprotinin, 10 lg/ml bestatin A, pH 7.4). All of these procedures were performed at 48C. According to previous work from our laboratory, none of the protease SPERM PROTEASOME, CAPACITATION, AND PROTEIN PHOSPHORYLATION inhibitors used, including TLCK, has a significant effect on the chymotrypsinlike activity of the sperm proteasome [20, 40] . The protein concentration in each sperm extract preparation was measured using the RC DC protein assay.
Enzymatic Activity
To determine the enzymatic activity of the sperm proteasome, motile sperm were incubated with 10 lM MG132 or its solvent. In others experiments, the sperm were incubated with 10 lM herbimycin A, 50 lM genistein, 10 lM H89, 50 lM tamoxifen, 1 nM St, 200 lM Rp-cAMPS or 500 lM 8-Br-cAMP for 30 min (T0), 5 h (T5) or 18 h (T18) at 378C, 5% CO 2 . Chymotrypsin-like activity was assayed using the fluorogenic substrate Suc-LLVY-AMC [35] . Briefly, 50-ll aliquots were incubated in a final volume of 995 ll homogenization buffer for 15 min at 378C, 5% CO 2 , before adding the 10-lM substrate. The assay was run at 378C, and the fluorescence was monitored with excitation at 380 nm and emission at 460 in a Shimadzu 1501 spectrofluorometer (Kyoto, Japan), as described previously [35] .
SDS-PAGE and Immunoblotting
Aliquots of highly motile sperm, selected by Percoll gradient, were divided into four groups: 1) noncapacitated (T0); 2) incubated for 5 h at 378C, 5% CO 2 (T5); 3) incubated for 18 h under the same conditions (T18); and 4) incubated with 10 lM epoxomicin during capacitation (T18 þ E). Controls aliquots were treated with the inhibitor solvent.
To carry out denaturing SDS-PAGE, sperm extracts were boiled for 5 min with sample buffer (500 lM Tris-HCl, 10% SDS, 30% glycerol, 0.5% bmercaptoethanol, and 0.5% bromophenol blue, pH 6.8) and then immediately settled on ice. Samples (20 lg) were resolved on 12% SDS-PAGE (12% acrylamide/bisacrylamide for the resolving gel and 5% acrylamide/bisacrylamide for the stacking gel) in a Mini Protean Cell (Bio-Rad Laboratories, Inc., Hercules, CA) [41] .
Electrophoretic transfer of proteins to polyvinylidene fluoride (PVDF) membranes in all experiments was carried out according to the method of Towbin et al. [42] , at 150 V for 1 h at 48C. Transfer was monitored by Ponceau red stain. The membrane was then blocked (5% BSA in Tris-buffered saline [TBS]; 3% milk and 5% BSA in TBS; or 3% milk in PBS), washed six times, and incubated with primary antibody at 48C overnight. Blots were washed six times and incubated with the appropriate biotinylated secondary antibody for 1 h at room temperature. The membrane was again washed as described above, and then the phosphorylated proteins were detected using an enhanced chemiluminescence kit (Amersham Corp., Sydney, Australia), according to the manufacturer's instructions. Prestained protein standards were used with a molecular mass range of approximately 149-14 kDa. Finally, the image analysis system, Scion Image 4.0.2 (Center for Information Technology, NIH, Bethesda, MD), was used to quantify the changes in intensity of various bands [43] .
Immunoprecipitation
Sperm at T0, T18, and at T18 with 10 lM H89 or 50 lM genistein were immunoprecipitated with an anti-proteasome subunit a-4 antibody immobilized with agarose at 7 ll/400 lg of protein, as described previously [43] . The reaction mixture was incubated on an orbital shaker overnight at 48C. The immune complex was obtained by centrifugation (15 000 3 g, 30 sec). The supernatants were discarded, and the pellets were washed twice with RIPA buffer and once with TBS. The washed pellets were mixed with SDS sample buffer (23) and heated in a boiling water bath for 5 min, and the supernatant was subjected to SDS-PAGE. The proteins on the gels were transferred to a PVDF membrane and detected as described above.
Stripping PVDF
To confirm equal protein loading, blots were stripped and reprobed with an antibody against the a-4 proteasome subunit. For this procedure, approximately 20 ml of stripping buffer (2% [w/v] SDS, 62.5 mM Tris, pH 6.7, and 100 mM 2-mercaptoethanol) was added to the membrane for 30 min with constant shaking at 608C. The membrane was then washed, blocked, and probed with the primary antibody, as previously described [43] .
Statistical Analysis
Data were analyzed using one-way analysis of variance and the t-test for unequal replicate using the Instat Program (GraphPad, La Jolla, CA). A difference with P , 0.05 was considered significant.
RESULTS
Proteasome and Sperm Capacitation
To elucidate the role of the sperm proteasome during capacitation, we evaluated this process using the CTC assay (Fig. 1 ). There was a significant increase in the percent of capacitated sperm at T18, and a significant reduction when capacitation took place in the presence of epoxomicin or MG132, potent and specific inhibitors of proteasomal activity [44] (Fig. 1) . These results agree with those obtained when the capacitation state of the spermatozoa was evaluated by their ability to undergo the progesterone-induced acrosome reaction (Fig. 2) . Sperm were incubated for 18 h with MG132, a reversible proteasome inhibitor, or its solvent. Aliquots were then washed and resuspended twice in fresh medium to remove
during capacitation, the sperm were not able to undergo the progesterone-induced acrosome reaction (Fig. 2) .
In parallel experiments, we measured the enzymatic activity of the sperm proteasome during treatment with both inhibitors (Fig. 3) . The chymotrypsin-like activity decreased to less than 5% of the control when the sperm were incubated in the presence of either inhibitor; however, in agreement with the reversible nature of MG132, the enzymatic activity of the proteasome was not different from the control when MG132 was removed shortly before the assay (Fig. 3, MG132w) . This experiment indicates that both compounds are potent and specific inhibitors of the sperm proteasome, that sperm washing was successful in removing the proteasome inhibitor MG132, and that the chymotrypsin-like activity of spermatozoa is entirely due to the proteasome. Since similar results with regard to capacitation and proteasome activity were obtained with MG132 and epoxomicin, only epoxomicin was used in the subsequent experiments.
To examine whether the proteasome is involved in the changes in protein phosphorylation that take place during capacitation, cells were incubated for 18 h in the presence of 10 lM epoxomicin, and sperm extracts were evaluated to determine protein phosphorylation (Fig. 4) . Western blot analysis revealed that T0 sperm exhibited several protein bands phosphorylated at serine residues, with molecular masses of approximately 134, 120, 107, 99, 42, and 27 kDa. The proteins phosphorylated at serine residues increased during capacitation at both T5 and T18, especially in the high molecular mass range. However, when sperm were treated with epoxomicin during capacitation (T18 þ E), they did not exhibit this increase to the degree of protein phosphorylation at serine residues (Fig. 4A) .
With regard to the pattern of protein phosphorylation at threonine residues, densitometric analysis revealed a gradual increase in the degree of phosphorylation during capacitation of bands in the range of 124-23 kDa. When the sperm were capacitated in the presence of epoxomicin, however, the degree of protein phosphorylation at threonine residues increased, especially in bands of 124 and 115 kDa (Fig. 4B) .
When the phosphorylation pattern at tyrosine residues was analyzed during capacitation, a clear increase in phosphorylation was seen for bands in the range of 115-27 kDa. This phosphorylation pattern was not affected by capacitating the sperm in the presence of the proteasome inhibitor (Fig. 4C) . This result was not surprising, given that sperm proteasomes are concentrated in the neck region near the centrioles [34] . Some proteasome labeling has also been detected at the periphery of the head, acrosomal, and postacrosomal regions, and in the connecting piece [45] , but there are no proteasomes located in the flagellum.
These results strongly suggest that the sperm proteasome is involved in the capacitation process. The proteasome may modulate protein phosphorylation at serine and threonine residues, directly or indirectly.
On the other hand, we wanted to establish whether this catalytic complex is involved in the cAMP production that has been reported to take place during capacitation. To this end, we measured the total cAMP concentration with the Direct Biotrak EIA system kit. The results demonstrate that the concentration of cAMP rose during the 18 h of incubation (48 6 3.5 fmol/10 3 10 6 sperm/ml at T0 to 138 6 8 fmol/10 3 10 6 sperm/ml at T18). This increase in cAMP production during sperm capacitation, however, did not change when the sperm were treated with epoxomicin (120 6 8 fmol/10 3 10 6 sperm/ml at T18 þ epoxomicin).
PKs and the Sperm Proteasome
Next, we evaluated the role of PKs during capacitation (Fig.  5) and their involvement in regulating the enzymatic activity of the proteasome (Fig. 6) . As reported by others [46] , PKA, PKC, and TK inhibitors prevented human sperm capacitation (Fig. 5) . In addition, the results indicate that incubation with 10 lM H89, 10 lM herbimycin A, and 50 lM genistein inhibited the chymotrypsin-like activity of the sperm proteasome at all capacitation times (P , 0.05) (Fig. 6, A and B) . PKC inhibitors, such as tamoxifen or St, did not affect sperm proteasomal activity (Fig. 6C) . The importance of PKA in the modulation of proteasomal activity was corroborated by the use of Rp-cAMPS (a PKA inhibitor) and 8-Br-cAMP (a PKA activator). When the sperm were incubated for 18 h with RpcAMPS, the chymotrypsin-like activity of the sperm proteasome was significantly decreased in comparison with the control (Fig. 6A) . In contrast, when the sperm were incubated for 18 h with 8-Br-cAMP, the chymotrypsin-like activity of the sperm proteasome was significantly increased in comparison to the control (Fig. 6A) .
Finally, the next experiments were designed to determine whether the chymotrypsin-like activity of the sperm proteasome is modulated by the degree of phosphorylation of its subunits during capacitation (Fig. 7) . T0 or T18 sperm aliquots were incubated in the presence or absence of H89 or herbimycin A. The chymotrypsin-like activity of the proteasome was then evaluated (Fig. 7, upper panel) , and the degree of phosphorylation of the proteasome subunits or its associating proteins was probed with different antibodies following immunoprecipitation (Fig. 7, lower panel) . The results reveal that the chymotrypsin-like activity of the proteasome doubled during capacitation, and that this increase was prevented by H89 and herbimycin A (Fig. 7, upper panel) . With regard to the phosphorylation pattern, bands of 67 and 24 kDa were phosphorylated at serine residues (Fig. 7A) , bands of 94 and 77 kDa were slightly phosphorylated at threonine residues, and SPERM PROTEASOME, CAPACITATION, AND PROTEIN PHOSPHORYLATION bands of 101 and 43 kDa were faintly phosphorylated at tyrosine residues in T0 sperm (Fig. 7, B and C) . With regard to serine, the degree of phosphorylation increased slightly during 18 h of incubation. On the other hand, phosphorylation at threonine and tyrosine residues exhibited great increases during capacitation. In all three cases, an increase in proteasome subunit phosphorylation during capacitation did not take place when the sperm were treated with H89 or herbimycin A (Fig.  7) .
DISCUSSION
In this work, we present evidence strongly suggesting that the proteasome plays a significant role during human sperm capacitation. The capacitation state was evaluated directly with the CTC assay, and indirectly by assessing the ability of the sperm to undergo the acrosome reaction when stimulated with progesterone. The CTC assay indicated that about 40% of the sperm were capacitated after 18 h of incubation. Similar results have been reported by others [37, 38] . The percentage of capacitated sperm only increased to about 13%, however, when the cells were incubated in the presence of the proteasome inhibitors, MG132 or epoxomicin. In addition, the progesterone-induced acrosome reaction assay confirmed similar inhibition of capacitation by MG132. When the potent, reversible, and cell-permeable proteasome inhibitor, MG132 [44] , was present during capacitation and induction of the acrosome reaction, the sperm did not undergo exocytosis of the acrosome. More importantly, after the sperm were washed free of MG132, resuspended in fresh medium, and treated with progesterone, they were still unable to undergo the acrosome reaction. The chymotrypsin-like activity of the sperm proteasome was significantly reduced by the presence of both inhibitors. MG132 is a peptide aldehyde that inhibits ubiquitinmediated proteolysis by binding to and inactivating the 20S and 26S proteasome [44] , and its activity is reversible [47] . Epoxomicin is a cell-permeable, natural product that potently, selectively, and irreversibly inhibits proteasome activity. Epoxomicin modifies four catalytic subunits of the 20S proteasome, primarily resulting in the inhibition of the   FIG. 4 . Effect of the proteasome inhibitor epoxomicin (E) on the phosphoprotein content of sperm extracts. Proteins were extracted from noncapacitated sperm (T0), sperm capacitated for 5 h (T5), and sperm capacitated for 18 h in the presence (T18 þ E) or absence of epoxomicin (T18). The phosphoserine (A), phosphothreonine (B), and phosphotyrosine (C) contents were then analyzed by immunoblotting with the antibodies described in the Materials and Methods. The numbers on the left-hand side of the immunoblots indicate the molecular mass (kDa) of the major phosphoproteincontaining bands. On the right-hand side, the densitometric analysis of the bands is shown (mean 6 SEM of three experiments). *P , 0.01 in comparison to the T18 group. A representative gel of three is shown.
chymotrypsin-like activity [48] . Thus, the results of these two assays confirmed the involvement of the proteasome during human sperm capacitation.
In the next series of experiments, we confirmed the hypothesis that the sperm proteasome is involved in the protein phosphorylation that takes place during human sperm capacitation. In fact, treatment with epoxomicin during capacitation modified the pattern of protein phosphorylation at both threonine and serine residues. Moreover, there seemed to be a bidirectional relationship between the proteasome and PKA, since inhibition of PKA caused a decrease in proteasome activity, as well as a decrease in the degree of phosphorylation of proteasome subunits (or its associating proteins).
In this work, we did not find evidence that the sperm proteasome is involved in protein tyrosine phosphorylation. It has previously been shown that the major phosphotyrosinecontaining proteins that become phosphorylated during capacitation are located in the fibrous sheath of the sperm flagellum [7, 49] . The proteasome is not located in the flagellum; therefore, it was not surprising that we did not find a relationship between this protease and the major proteins that become phosphorylated at tyrosine residues during capacitation.
Because of methodological problems, phosphorylation of serine and threonine is difficult to detect. Only one article dealing with activation of the serine/threonine phosphorylation cascade during capacitation has been published [50] . In the present work, several proteins showed increased phosphorylation at serine and threonine residues during capacitation. Some of these proteins coincided with those described by Naz [50] specifically those of 27, 42, 99, and 107-120 kDa for serine, and those of 23, 36, 57, 93, and 100-124 kDa for threonine.
The proteasome is a multicatalytic complex present in mammalian sperm of several species, including humans [20, 21, 34, 35, 51] . Previous reports have established that the proteasome actively participates in calcium influx and the acrosome reaction induced by both the zona pellucida and progesterone [35, 52] . To the best of our knowledge, however, this is the first report to show that the proteasome has a role during human sperm capacitation.
Sperm capacitation is a process that is correlated with modifications at the molecular and immunological levels, which prepare the sperm for physiological changes, such as ''hyperactivation'' and the acrosome reaction [1] . Some of the changes described as taking place during human sperm capacitation include an increase in membrane fluidity, cholesterol efflux [2] , ion fluxes resulting in membrane hyperpolarization [3] , and an increase in the degree of protein phosphorylation at tyrosine and serine/threonine residues, SPERM PROTEASOME, CAPACITATION, AND PROTEIN PHOSPHORYLATION which appears to be crucial for the sperm to fertilize an oocyte [8, 9, 14] . A complex balance between kinase and phosphatase activities regulates sperm protein phosphorylation. Different PKs have been described in mammalian sperm, including TK [10] , PKA (PRKA) [11] , PKC (PRKC) [10, 12] , glycogen synthase kinase 3b (GSK3) [13] , casein kinase II (CK2, CSNK2) [53] , extracellular signal-regulated kinase (MAPK) [54] , and Ca 2þ /calmodulin-dependent protein kinase (CAM kinase, CAMK) [55] . In addition, serine/threonine-specific protein phosphatase (PP) activity has been identified in spermatozoa from different species, and is involved in the regulation of sperm motility [56] . The Ca 2þ /calmodulindependent phosphatase calcineurin (PP2B, PPP3C) has been detected in dog sperm [57] , among others.
The intracellular signaling pathways that lead to an increase in the degree of sperm protein phosphorylation during capacitation are not fully understood. Here, we present evidence that the proteasome may be modulating this phosphorylation. We have shown a decrease in phosphorylation at serine residues in proteins between 134 and 99 kDa when the sperm are treated with epoxomicin during capacitation. This suggests that the proteasome may be involved in the degradation of a serine phosphatase during capacitation. On the other hand, proteins containing phosphothreonine residues increased in bands in the range of 124-115 kDa and 73-29 kDa when the sperm were treated with epoxomicin during capacitation. This suggests that the proteasome may be involved in the degradation of threonine kinases during capacitation. Alternatively, the proteasome may be involved in the degradation of several proteins that are phosphorylated at threonine residues as a trigger for proteolysis.
There is information in the literature regarding the modulation of kinase and phosphatase proteins by the proteasome [58] [59] [60] . In salmon sperm, the proteasomes are located along the flagella, where they may be involved in cAMP-dependent phosphorylation of the axonemal protein of 22 kDa, dynein light chain [61, 62] . In Aplysia neurons, regulatory subunits of PKA have been shown to be a substrate for degradation via the ubiquitin-proteasome system [63] . The same condition was described for the G protein-coupled receptor kinase 2 (GRK2, ADRBK1), which is degraded by activation of b2-adrenergic receptors in human embryonic kidney-293 cells [64] . Other authors have demonstrated that ERK1/2 (mitogen-activated PK [MAPK] 3/1) activation can enhance MAPK phosphatase 1 (MKP-1, DUSP1) [65] and MKP-3 [66] degradation by the proteasome. On the other hand, several studies have shown that protein phosphorylation at serine residues is a signal that triggers proteolysis by the proteasome [66] [67] [68] . In 1999, Yano et al. [69] reported a new function for the purified 20S proteasome obtained from a human lymphoblastoma cell line. They demonstrated that the proteasome exhibits intrinsic nucleoside diphosphate kinaselike activity. Whether this finding is related to a diminution in the degree of phosphorylation at serine residues observed in sperm treated with epoxomicin in our study is currently unknown.
Now that we know that the sperm proteasome has a role in degrading or modulating necessary proteins so that the capacitation process can take place, it is important to investigate the mechanisms of activation or maintenance of its enzymatic activity during this stage. Our results show that the chymotrypsin-like activity of the proteasome increased during capacitation, and that, when the sperm were incubated with PKA and TK inhibitors, this enzymatic activity decreased. Nevertheless, the enzymatic activity was not modified when the sperm were treated with PKC inhibitors. This observation is in agreement with the work of Marambaud et al. [70] , which suggested a role for PKA during proteasome phosphorylation in HK 293 cells, and showed that incubation of the cells with forskolin increased proteasome activity. More recently, it was reported that the chymotrypsin-like and trypsin-like activities of the proteasome are directly stimulated by PKA phosphorylation at serine 120 of the ATPase subunit of the AAA type (Rpt6) in normal rat kidney cells [71] . On the other hand, a recent report did not find an increase in the PGPH activity of the human sperm proteasome during capacitation [72] . We also failed to find an increase in the sperm proteasome PGPH activity during capacitation (data not shown).
Numerous studies have shown that proteasome subunits are phosphorylated in cells of several species. For example, the a-3, a-5, and a-6 subunits of Candida albicans, the a-3 subunit of yeast [24] , and the C9 subunit in mammalian cells [73] are all phosphorylated. The work of Satoh et al. [28] has indicated that the phosphorylation of subunits in the 19S complex (p45) might be important for 26S proteasome stability. Likewise, Bose et al. [27] showed that the phosphorylation of the C8 a-7 subunit in the 20S proteasome affected the assembly of the 19S   FIG. 7 . The effect of H89 (H89) and herbimycin A (HA) on the chymotrypsin-like activity (upper panel) and on serine, threonine, and tyrosine phosphorylation (lower panels) of the human sperm proteasome during capacitation. Sperm aliquots were incubated in culture medium for 30 min (T0) or 18 h (T18) in the presence of 10 lM H89 (black bar), 10 lM herbimycin A (striped bar) or 0.1% DMSO (control, white bars). The chymotrypsin-like activity of the sperm proteasome was then measured using the fluorogenic substrate, Suc-LLVY-AMC. *P , 0.01 in comparison to the control group. In the lower panels, extracts of noncapacitated sperm (T0), sperm capacitated for 18 h (T18), and sperm capacitated for 18 h in the presence of 10 lM H89 (H89) or 10 lM herbimycin A (HA) were immunoprecipitated with an anti-proteasome antibody and detected with an anti-phosphoserine antibody (A), an anti-phosphothreonine antibody (B), or an anti-phosphotyrosine antibody (C). The membrane was then stripped and reprobed by using an anti-a4 proteasome antibody. The Western blot is representative of two independent experiments. The numbers on the left-hand side of the immunoblots indicate the molecular mass (kDa) of the major phosphoprotein-containing bands.
complex to the 20S proteasome, via changes in the charge of the C-terminal or local conformational changes.
In the present report, we present evidence, for the first time, that the human sperm proteasome (or the proteasomeassociating proteins) becomes phosphorylated at serine, threonine, and tyrosine residues during capacitation, and that this process is modulated by PKA and TK. We also recently reported that, during the fibronectin-induced acrosome reaction, the human sperm proteasome becomes phosphorylated at tyrosine residues [43] . In addition, it was recently shown that the proteasome a subunit type 6b undergoes tyrosine phosphorylation during capacitation in the mouse [74] .
There are some reports related to the effect of TK on phosphorylation at serine/threonine residues. On the other hand, regulation of protein tyrosine phosphorylation by PKA is well known in spermatozoa. In fact, the increase in tyrosine phosphorylation of proteins of 105 and 80 kDa during human sperm capacitation is associated with the activity of cAMP/ PKA [49, [75] [76] [77] [78] , and the phosphorylation of PKA substrates (Arg-X-X-Ser/Thr) is blocked by TK inhibitors, but not by PKC inhibitors [79] . In knockout mice that lack C2a, the testicle-specific catalytic subunit of PKA, sperm cannot move actively, and cannot undergo the normal increase in tyrosine phosphorylation observed in wild-type sperm [80] . In addition, mouse spermatozoa that lack soluble adenylate cyclase do not exhibit changes in the pattern of protein tyrosine phosphorylation during capacitation [81, 82] . With regard to the influence of TK upon serine/threonine phosphorylation, it was reported in cardiac myocytes that treatment with endothelin-1 increased phosphorylation of PKCd (PRKCD) at tyrosine residues; this increase was correlated with an increase in diacylglycerolindependent activity of the enzyme [83] . There is also evidence that adenylate cyclase can be activated by TK [84] , thus increasing the generation of cAMP and activating PKA. TKdependent activation of adenylate cyclase, independent of G protein activation, has been reported in human mononuclear leukocytes and vascular smooth muscle cells, and appears to involve raf kinase-mediated serine phosphorylation [85] . Whether the soluble adenylate cyclase, characterized as the predominant form in mammalian sperm [86] , is sensitive to activation by TK is not known. Finally, it has been reported that PP1C is phosphorylated in vitro by the protein TK, pp60 [87] , which decreases phosphatase activity by 50%, while PP2A is subject to tyrosine phosphorylation at Tyr307 [88] . Tyrosine phosphorylation potently inhibits PP2A activity [88] .
Finally, we observed that, while the phosphorylation level of the proteasome increased during capacitation, the chymotrypsin-like activity increased concomitantly between noncapacitated and capacitated sperm. When proteasome phosphorylation was inhibited by PKA and TK inhibitors, its activity decreased, and capacitation did not take place. We still do not know the exact relationship between phosphorylation of proteasome subunits and its enzymatic activity. Further studies are needed to understand which subunits become phosphorylated, and how this affects enzymatic activity.
In summary, we report here that the proteasome plays a role during human sperm capacitation, and that PKs are involved in the regulation of its activity.
